Evidence map›Paper›PMID 16450016›Full record

GuidelineThe Canadian journal of cardiology2006

Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.

J Malcolm O Arnold, Peter Liu, Catherine Demers, Paul Dorian, Nadia Giannetti, Haissam Haddad, George A Heckman, Jonathan G Howlett, Andrew Ignaszewski, David E Johnstone and 12 more

Erratum issued Registry-linked trialOpen access · bronzeAbstract readConsensus StatementPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in The Canadian journal of cardiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT01772108 (A Randomized Study of the MitraClip Device in Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation), which is not on this map. Cited by 109 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 9 pooled it
19.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01772108 naterminatednot on this mapstarted 2013, after this paper: background citation

A Randomized Study of the MitraClip Device in Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation

TypeinterventionalSponsorAbbott Medical DevicesRan2013 to 2015Enrolled42ConditionsCardiovascular DiseasesArmsMitraClip
3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 9 syntheses or guidelines pooled it, 417 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Angiotensin receptor blockers for heart failure.The Cochrane database of systematic reviews · 2012
    Pooled it
  4. Guideline
  5. Guideline
  6. Guideline
  7. Guideline
  8. Pooled it
  9. Guideline
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

22 authors at 12 institutions in 1 country.

J Malcolm O ArnoldUniversity of Western Ontario, London, Canada. malcolm.arnold@lhsc.on.ca
Peter Liu
Catherine Demers
Paul Dorian
Nadia Giannetti
Haissam Haddad
George A Heckman
Jonathan G Howlett
Andrew Ignaszewski
David E Johnstone
Philip Jong
Robert S McKelvie
Gordon W Moe
John D Parker
Vivek Rao
Heather J Ross
Errol J Sequeira
Anna M Svendsen
Koon Teo
Ross T Tsuyuki
Michel White
Canadian Cardiovascular Society
McMaster University · CAQueen Elizabeth II Health Sciences Centre · CAUniversity of Toronto · CACredit Valley Hospital · CAMcGill University · CAMontreal Heart Institute · CAMount Sinai Hospital · CAOttawa Heart InstituteSt. Paul's Hospital · CAToronto General Hospital · CAUniversity of Alberta · CAWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure remains a common diagnosis, especially in older individuals. It continues to be associated with significant morbidity and mortality, but major advances in both diagnosis and management have occurred and will continue to improve symptoms and other outcomes in patients. The Canadian Cardiovascular Society published its first consensus conference recommendations on the diagnosis and management of heart failure in 1994, followed by two brief updates, and reconvened this consensus conference to provide a comprehensive review of current knowledge and management strategies. New clinical trial evidence and meta-analyses were critically reviewed by a multidisciplinary primary panel who developed both recommendations and practical tips, which were reviewed by a secondary panel. The resulting document is intended to provide practical advice for specialists, family physicians, nurses, pharmacists and others who are involved in the care of heart failure patients. Management of heart failure begins with an accurate diagnosis, and requires rational combination drug therapy, individualization of care for each patient (based on their symptoms, clinical presentation and disease severity), appropriate mechanical interventions including revascularization and devices, collaborative efforts among health care professionals, and education and cooperation of the patient and their immediate caregivers. The goal is to translate best evidence-based therapies into clinical practice with a measureable impact on the health of heart failure patients in Canada.

Indexed as

CanadaCardiac Surgical ProceduresCardiologyCardiovascular AgentsDefibrillators, ImplantableExercise TherapyHeart FailureHumansSocieties, MedicalCardiovascular Agents

Identifiers

PMID16450016
PMCPMC2538984
OpenAlexW2143310754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.